Growth Equity
Blue Wolf Capital Partners
Blue Wolf Capital Partners takes minority stakes in growing companies, usually without full control, from New York, United States. It states a focus on healthcare & life sciences, financial services, environmental & safety and industrials & manufacturing.
Stated investment criteria
What Blue Wolf Capital Partners says it buys
Read from Blue Wolf Capital Partners’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.
A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Blue Wolf Capital Partners to consider any particular business, and nothing on this page is represented as being for sale.
Regulatory record
How Blue Wolf Capital Partners is registered
From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.
| Adviser status | SEC registered |
| Regulatory assets under management | $4.1bn |
| Employees | 51 |
| Private funds advised | 14 · $3.5bn gross |
| SEC adviser number | CRD 162475 |
Recorded transactions
Buying and selling
Deals in which Blue Wolf Capital Partners is named as buyer or seller in the transaction archive. 1 recorded exit, most recently in 2021. 1 recorded acquisition.
| Company | Side | Counterparty | Year | Consideration |
|---|---|---|---|---|
| CQ Medical | Bought | Roper Technologies | 2021 | $120m |
| Novo Building Products | Sold | ADENTRA | 2021 | $303m |
Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this Blue Wolf Capital Partners?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other growth equity investors active in healthcare & life sciences.